Keywords: phase, iib, trial, go, ahead, movetis, ascites

Phase IIb trial to go ahead for Movetis' ascites candidate

Article | 07 July 2008

Print This

Belgian specialist pharmaceutical company Movetis has announced it will progress its M0002 candidate for the treatment of ascites into Phase ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in